The role of dendritic cell subtypes in the pathophysiology of atopic dermatitis - 21/08/11
, Thomas Bieber, MD, PhD
Reprint requests: Natalija Novak, MD, Department of Dermatology, University of Bonn, Sigmund-Freud-Str 25, 53105 Bonn, Germany.Bonn, Germany
Abstract |
Background |
Atopic dermatitis (AD) is an inflammatory, immunologically mediated skin disease characterized by a T helper type 2 cell–predominant phenotype initially with additional acquisition of T helper type 1 cell phenotype during the chronic eczematous phase. Compelling evidence presented here suggests that two types of dendritic cells (DC), myeloid DC (mDC) and plasmacytoid DC (pDC), are important in the pathogenesis of AD.
Methods |
We reviewed the current literature and summarized key information about the role of mDC and pDC in the pathogenesis of AD.
Results |
Langerhans cells and inflammatory dendritic epidermal cells, which bear the high-affinity receptor for immunoglobulin E on their cell surface, are hypothesized to contribute to the pathogenesis of AD. pDC, Which play an important role in the defence against viral infections, have also been shown to express high-affinity receptor for immunoglobulin E.
Conclusion |
Immunoglobulin E receptor–bearing mDC and pDC subtypes in the blood and the skin of patients with AD are of critical immunologic importance in the complex pathophysiologic network of AD. Targeting mDC and pDC subtypes may lead to effective new therapies for the management of AD.
Le texte complet de cet article est disponible en PDF.Abbreviations used : AD, DC, DC1, DC2, FcεRI, IDEC, IFN, IgE, IL, LC, mDC, pDC, Th2, TSLP
Plan
| Supported by grants from the Deutsche Forschungsgemeinschaft No 454/2-1 and No 454/1-1 and BONFOR. Conflicts of interest: None identified. |
Vol 53 - N° 2S2
P. S171-S176 - août 2005 Retour au numéro
Article précédent
- The efficacy and safety of tacrolimus ointment: A clinical review
- Lisa A. Beck
- Tacrolimus ointment 0.03% shows efficacy and safety in pediatric and adult patients with mild to moderate atopic dermatitis
- M. Shane Chapman, Lawrence A. Schachner, Debra Breneman, Mark Boguniewicz, Michael H. Gold, Toni Shull, Gregory J. Linowski, Eileen Jaracz, for the US Tacrolimus Ointment Study Group ∗
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?